Axiom Presents "Benefits and Advantages of a Unified Platform Approach to Global Studies" at Outsourcing in Clinical Trials East Coast 2021
25 mai 2021 09h18 HE
|
Axiom Real-Time Metrics Inc
TORONTO, May 25, 2021 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics ("Axiom"), premier provider of unified eClinical solutions and services focused on small-to-medium life science organizations, will...
Dimensions Health Centres Announces Closing of First Treatment Center on Maple Lake in the Algonquin Highlands
25 mai 2021 08h30 HE
|
Dimensions Health Centres
TORONTO, May 25, 2021 (GLOBE NEWSWIRE) -- Dimensions Health Centres (“Dimensions”), a psychedelic treatment company focused on inpatient treatment integrating neuroscience with traditional healing...
PDS Biotech Announces Release of Abstract for PDS0101 in NCI-Led Phase 2 Clinical Study for Oral Presentation at 2021 ASCO Meeting
20 mai 2021 08h00 HE
|
PDS Biotechnology Corporation
FLORHAM PARK, N.J., May 20, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies based on the Company’s...
Global Gamma Delta T Cell Cancer Therapy Opportunity & Clinical Trials Insight Report 2021-2026 Featuring Acopedia, Takeda Pharma, TC Biopharma and Adapate Therapeutics
20 mai 2021 05h58 HE
|
Research and Markets
Dublin, May 20, 2021 (GLOBE NEWSWIRE) -- The "Global Gamma Delta T Cell Cancer Therapy Opportunity & Clinical Trials Insight 2026" report has been added to ResearchAndMarkets.com's offering. ...
Rubius Therapeutics to Present Trials in Progress Poster on the Phase 1 Clinical Trial of RTX-321 for HPV 16-Positive Cancers at the 2021 American Society of Clinical Oncology Annual Meeting
19 mai 2021 17h02 HE
|
Rubius Therapeutics
CAMBRIDGE, Mass., May 19, 2021 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq:RUBY), a clinical-stage biopharmaceutical company that is genetically engineering red blood cells to create an...
Burning Rock Announces the Launch of China’s First Prospective Pan-Cancer Multi-omics Early Detection Study
19 mai 2021 05h06 HE
|
Burning Rock Biotech Limited
BEIJING, May 19, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”) today announced the launch of the PRESCIENT (Pan-canceR Early-Stage deteCtion by...
PRA Health Sciences pioneers connecting clinical trial patients with their real-world data with Synoma
13 mai 2021 16h02 HE
|
PRA Health Sciences, Inc.
RALEIGH, N.C., May 13, 2021 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) announced today an innovative tokenization solution using Synoma®, PRA’s proprietary technology that allows...
Innovation Pharma Files Form 10-Q; Patient Enrollment in Phase 2 Clinical Trial of Brilacidin for COVID-19 Tops 70 Percent
13 mai 2021 08h00 HE
|
Innovation Pharmaceuticals Inc.
WAKEFIELD, Mass., May 13, 2021 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, today announces the filing of its SEC Form...
Certara Releases New Versions of Its Preeminent Quantitative Systems Pharmacology (QSP) Simulators for Expediting Development of Biologics and Immuno-oncology Therapies
13 mai 2021 08h00 HE
|
Certara
PRINCETON, N.J., May 13, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), the global leader in biosimulation, today announced the launch of new versions of its Immunogenicity (IG) and...
CrannMed partners with leading Digital Research Organization, Meditrial to obtain “Breakthrough Device Designation” by the FDA for its innovative Knee Osteoarthritis Therapy
13 mai 2021 06h00 HE
|
Meditrial
NEW YORK, May 13, 2021 (GLOBE NEWSWIRE) -- Meditrial Inc, a leading Global Digitally Driven Research Organization, is pleased to announce its successful collaboration with CrannMed Limited in...